Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
6.01
-0.28 (-4.45%)
At close: Apr 1, 2025, 4:00 PM
5.87
-0.14 (-2.33%)
After-hours: Apr 1, 2025, 4:08 PM EDT

Trevi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
581368861162044
Upgrade
Market Cap Growth
330.28%330.28%-26.01%472.04%-54.55%-33.49%
Upgrade
Enterprise Value
456304-2165
Upgrade
Last Close Price
6.294.121.341.930.782.42
Upgrade
PB Ratio
5.913.701.041.081.181.63
Upgrade
P/TBV Ratio
3.703.701.041.081.181.63
Upgrade
Debt / Equity Ratio
0.010.010.020.090.860.52
Upgrade
Quick Ratio
10.2910.2914.338.992.908.10
Upgrade
Current Ratio
10.4110.4115.039.152.988.33
Upgrade
Return on Equity (ROE)
-52.59%-52.59%-30.59%-46.82%-153.03%-80.07%
Upgrade
Return on Assets (ROA)
-32.15%-32.15%-19.96%-23.15%-47.42%-37.91%
Upgrade
Return on Capital (ROIC)
-34.90%-34.90%-21.15%-25.18%-55.37%-42.13%
Upgrade
Earnings Yield
-8.52%-13.01%-33.97%-25.21%-167.88%-73.64%
Upgrade
FCF Yield
-6.81%-10.40%-37.22%-24.50%-143.18%-65.27%
Upgrade
Buyback Yield / Dilution
-2.97%-2.97%-53.44%-182.56%-26.48%-53.88%
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q